To face the COVID-19 outbreak, a wide range of non-pharmaceutical interventions (NPIs)
aimed at limiting the spread of the virus in communities, such as mask-wearing, hand …

Respiratory syncytial virus (RSV) infections are a constant public health problem, especially
in infants and older adults. Virtually all children will have been infected with RSV by the age …

Importance Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract
infections (LRTIs) and infant hospitalization worldwide. Objective To evaluate the …

As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …

The genetic mutability of the influenza virus leads to the existence of drug-resistant strains
which is dangerous, particularly with the lingering coronavirus disease (COVID-19). This …

Summary Background Lower respiratory infections (LRIs) are a major global contributor to
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …

Due to governments' actions to contain the spread of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), the activity of common circulating respiratory viruses was …

Respiratory syncytial virus (RSV) is a well-known infant pathogen transmitted mainly by
droplets. It is a leading cause of upper respiratory tract infections in children, usually with a …

Summary The coronavirus disease 2019 (COVID-19) pandemic has drastically perturbed
the epidemiology of Respiratory Syncytial Virus (RSV) respiratory tract infections in children …

Respiratory syncytial virus (RSV) is the most common pathogen causing respiratory tract
infections in infants, affecting over 90% of children within the first two years of life. It may …